Investigating Coordinated Removal of Old and Synthesis of New Materials in Neurons and how These Processes are Disrupted in FTD
Principal Investigator
Sarah Hill, PhD
The National Institute of Neurological Disorders and Stroke
Bethesda, MD, USA
About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$200,000
Active Dates
September 01, 2020 - August 31, 2022
Grant ID
A20201086F
Mentor(s)
Michael Ward, MD, PhD, Howard Hughes Medical Institute, Janelia Research Campus
Jennifer Lippincott-Swartz, PhD, Howard Hughes Medical Institute, Janelia Research Campus
Goals
Similar to how grocery stores maintain a full shelf of milk cartons by continually selling milk and obtaining new cartons, cells must balance the removal of old and synthesis of new materials. In neurons, insufficient removal of materials or defects in synthesis, lead to loss of neuronal function, accumulation of toxic aggregates, and ultimately neuron death, contributing to the pathogenesis of neurodegenerative diseases such as Frontotemporal Dementia (FTD). In this proposal I will examine how the distinct processes of removal and synthesis are interrelated. I will use imaging to determine their physical and temporal relationship, drugs to block removal and determine the effects on synthesis, and I will use neurons created from human cells to best determine the extent to which these processes occur during FTD.
Summary
Similar to how grocery stores maintain a full shelf of milk cartons by continually selling milk and obtaining new cartons, cells must balance the removal of old and synthesis of new materials. In neurons, insufficient removal of materials or defects in synthesis, lead to loss of neuronal function, accumulation of toxic aggregates, and ultimately neuron death, contributing to the pathogenesis of neurodegenerative diseases such as Frontotemporal Dementia (FTD). In this proposal I will examine how the distinct processes of removal and synthesis are interrelated. I will use imaging to determine their physical and temporal relationship, drugs to block removal and determine the effects on synthesis, and I will use neurons created from human cells to best determine the extent to which these processes occur during FTD.
Grants
Related Grants
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Alzheimer's Disease Research
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD
Alzheimer's Disease Research
Advancing the Promising Cerebroprotectant AST-004 to Human Clinical Trials
Active Dates
July 02, 2021 - June 30, 2024
Principal Investigator
William Korinek, PhD
Advancing the Promising Cerebroprotectant AST-004 to Human Clinical Trials
Active Dates
July 02, 2021 - June 30, 2024
Principal Investigator
William Korinek, PhD